Magnetic resonance evaluation of the presence of an extensive intraductal component in breast cancer

Acta Radiologica

Volumn 45, Issue 7, 2004, Pages 721-725

  Ikeda, O ^a   Nishimura, R ^a   Miyayama, H ^a   Yasunaga, T ^a   Ozaki, Y ^a   Tsuji, A ^a   Yamashita, Y ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Breast cancer; Extensive intraductal component; MR imaging

Indexed keywords

CORRELATION THEORY; DUCTS; HISTOLOGY; INFORMATION RETRIEVAL; MAGNETIC RESONANCE IMAGING; MEDICAL COMPUTING; SURGERY; SURVEYING; THREE DIMENSIONAL COMPUTER GRAPHICS;

BREAST CANCER; EXTENSIVE INTRADUCTAL COMPONENT; SEGMENTAL ENHANCEMENT (SE); SPOTTY OR LINEAR CONTINUOUS ENHANCEMENT (SLE);

TUMORS;

ADULT; AGED; ARTICLE; BREAST TUMOR; FEMALE; HUMAN; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PAGET NIPPLE DISEASE; PATHOLOGY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; SENSITIVITY AND SPECIFICITY;

EID: 16644389257     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850410001349     Document Type: Article

References (25)

1. Brown JJ, van Sonnenberg E, Gerber KH, Strich G, Wittich GR, Slutsky RA. Magnetic resonance relaxation time of percutaneously obtained normal and abnormal body fluid. Radiology 1985;154:727-31.
2. Dershaw DD, Abramson A, Kinne DW. Ductal carcinoma in situ: mammographic findings and clinical implications. Radiology 1989;170:411-15.
3. Gilles R, Zafrani B, Guinebretiere JM, Meunier M, Lucidarme O, Tardivon AA, et al. Ductal carcinoma in situ: MR imaging - histopathologic correlation. Radiology 1995;196:415-19.
4. Gimbrone MA Jr, Leapman SB, Cotran RS, Folkman J. Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 1972;136:261-76.
5. Harms SE, Flaming DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, et al. MR imaging of the breast with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 1993;187:493-501.
6. Heywang SH, Wolf A, Pruss E, Hibertz T, Eiermann W, Permanetter W. MR imaging of the breast with Gd- DTPA: use and limitations. Radiology 1989;171:95-103.
7. Hiramatsu H, Enomoto K, Ikeda T, Muaki M, Fukukaw J, Kikuchi K, et al. The role of contrast-enhanced high resolution MRI in the surgical planning of breast cancer. Breast Cancer 1997;4:285-90.
8. Hiramatsu H, Ikeda T, Enomoto K, Muaki M, Fukukaw J, Kikuchi K, et al. The role of MR mammography in breast-conserving theraphy. Jpn J Clin Radiol 1999;44:573-80.
9. Holland R, Hendriks JHCL, Verbeek AKM, Mravunac M, Schuurmans Stekhoven JH. Extent distribution and mammographic/histological correlation of breast ductal carcinoma in situ. Lancet 1990;335:519-22.
10. Kaiser WA, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989;170:681-6.
11. Kuroki Y, Nawano S, Hasebe T, Imoto S, Nasu K, Murakami K, et al. Efficacy of MR mammography (MRM) in providing preoperative locoregional information on breast cancer: correlation between MRM and histological findings. MRMS 2002;1:73-80.
12. Morris EA, Schwartz LH, Dershaw DD, von Zee KJ, Albramson AF, Liberman L. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997;205:437-40.
13. Morrow M, Schnitt SJ, Harris JR. In situ carcinoma. In: Harris JR, Lippman ME, Morrow M, Hellman S, editors. Diseases of the breast. Philadelphia: Lippincott-Raven; 1996. p. 355-68.
14. Mumtaz H, Hall-Craggs MA, Davidson T, Walmsley K, Thurell W, Kissin MW, et al. Staging of symptomatic primary breast cancer with MR imaging. Am J Roentgenol 1997;169:417-24.
15. Orel SG, Mendonca MH, Reynolds C, Schnall LJ, Sullivan DC. MR imaging of ductal carcinoma in situ. Radiology 1997;202:413-20.
16. Orel SG, Schnall MD, Powell CM, Hochman MG, Solin LJ, Fowble BL, et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995;196:115-22.
17. Pierce WB, Harms SE, Flamig DP, Griffey RH, Evans WP, Hagans JE. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast - work in progress. Radiology 1991;181:757-63.
18. Revel D, Brasch RC, Paajanen H, Rosenau W, Grodd W, Engelstad B, et al. Gd-DTPA contrast enhancement and tissue differentiation in MR imaging of experimental breast carcinoma. Radiology 1986;158:319-23.
19. Rubens D, Totterman S, Chacko AK, Kothari K, Logan-Young W, Szumowski J, et al. Gadopentate dimeglumine-enhanced chemical-shift MR imaging of the breast. Am J Roentgenol 1991;157:267-70.
20. Schnitt JS, Abner A, Gelman R, Connolly LJ, Recht A, Duda BR, et al. The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy. Cancer 1994;74:1746-51.
21. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990;174:491-4.
22. Stomper PC, Connolly JL, Meyer JE, Harris JR. Clinically occult ductal carcinoma in situ detected with mammography: analysis of 100 cases with radiologic-pathologic correlation. Radiology 1989;172: 235-41.
23. Stomper PC, Margolin FR. Ductal carcinoma in situ: the mammographer's perspective. Am J Roentgenol 1994;162:585-91.
24. Vicini FA, Eberlein TJ, Connolly JL, Recht A, Abner A, Schnitt JS, et al. The optimal extent of resection for patients with stages I or II breast cancer treated with conservative surgery and radiotherapy. Ann Surg 1991;214:200-4.
25. William H. National Institute of Health Consensus Conference. In: Treatment of early-stage breast cancer. JAMA 1991;265:391-5.